BiomX Inc. (PHGE)
0.54
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 4 BiomX Inc. For: Apr 14 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
April 18, 2025 5:29 PM - SEC Filing
Form 4 BiomX Inc. For: Apr 14 Filed by: LEFF JONATHAN S
April 18, 2025 4:01 PM - SEC Filing
Form 4 BiomX Inc. For: Apr 14 Filed by: Wolfson Marina
April 18, 2025 4:01 PM - SEC Filing
Form 4 BiomX Inc. For: Apr 14 Filed by: Bassan Merav
April 18, 2025 4:01 PM - SEC Filing
Form 4 BiomX Inc. For: Apr 14 Filed by: Merril Gregory Louis
April 18, 2025 4:01 PM - SEC Filing
Form 4 BiomX Inc. For: Apr 14 Filed by: GOODMAN JESSE
April 18, 2025 4:01 PM - SEC Filing
Form 4 BiomX Inc. For: Apr 14 Filed by: Greig Russell
April 18, 2025 4:01 PM - SEC Filing
Form 4 BiomX Inc. For: Apr 14 Filed by: Blum Susan
April 18, 2025 4:01 PM - SEC Filing
Form 4 BiomX Inc. For: Apr 14 Filed by: Williams Eddie
April 18, 2025 4:01 PM - SEC Filing
Form 4 BiomX Inc. For: Apr 14 Filed by: Solomon Jonathan Eitan
April 18, 2025 4:01 PM - SEC Filing
Form 4 BiomX Inc. For: Apr 14 Filed by: Moses Alan Charles
April 18, 2025 4:01 PM - SEC Filing
Form DEFA14A BiomX Inc.
April 17, 2025 5:22 PM - SEC Filing
Form S-1 BiomX Inc.
April 11, 2025 5:40 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on BiomX (PHGE)
April 4, 2025 6:44 AM - StreetInsider
Form DEFA14A BiomX Inc.
April 1, 2025 4:05 PM - SEC Filing
BiomX (PHGE) PT Raised to $21 at H.C. Wainwright
April 1, 2025 6:44 AM - StreetInsider
Form 8-K BiomX Inc. For: Mar 31
March 31, 2025 9:08 AM - SEC Filing
BiomX Inc. (PHGE) Announces Positive Topline Results from Phase 2 Trial of BX211
March 31, 2025 6:31 AM - StreetInsider
BiomX Announces Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO)
March 31, 2025 6:31 AM - Globe NewsWire
Form DEF 14A BiomX Inc. For: Apr 21
March 27, 2025 4:06 PM - SEC Filing
Form 10-K BiomX Inc. For: Dec 31
March 25, 2025 5:30 PM - SEC Filing
Form 8-K BiomX Inc. For: Mar 25
March 25, 2025 6:46 AM - SEC Filing
BiomX to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025
March 19, 2025 12:35 PM - Globe NewsWire
Form PRE 14A BiomX Inc. For: Mar 17
March 17, 2025 5:03 PM - SEC Filing
Form 8-K BiomX Inc. For: Feb 27
March 5, 2025 5:15 PM - SEC Filing
Form SCHEDULE 13G/A BiomX Inc. Filed by: Cystic Fibrosis Foundation
March 4, 2025 5:35 PM - SEC Filing
Form 4 BiomX Inc. For: Feb 26 Filed by: Cystic Fibrosis Foundation
March 4, 2025 4:36 PM - SEC Filing
Form 5 BiomX Inc. For: Jul 15 Filed by: Cystic Fibrosis Foundation
March 4, 2025 4:31 PM - SEC Filing
Form SCHEDULE 13D/A BiomX Inc. Filed by: Flynn James E
March 3, 2025 7:04 PM - SEC Filing
Form 4 BiomX Inc. For: Feb 27 Filed by: Deerfield Healthcare Innovations Fund II, L.P.
March 3, 2025 7:03 PM - SEC Filing
Form 8-K BiomX Inc. For: Feb 25
February 27, 2025 10:39 AM - SEC Filing
Form 424B5 BiomX Inc.
February 27, 2025 10:34 AM - SEC Filing
Form 424B3 BiomX Inc.
February 27, 2025 10:32 AM - SEC Filing
Form 424B5 BiomX Inc.
February 24, 2025 5:24 PM - SEC Filing
Form SCHEDULE 13G/A BiomX Inc. Filed by: Cystic Fibrosis Foundation
February 14, 2025 4:05 PM - SEC Filing
Full Article List
